Sichenzia Ross Ference LLP Represents H.C. Wainwright in $40.0 Million Registered Direct Offering of Pulmatrix, Inc.

Press Release – New York, NY – February 17, 2020 – Sichenzia Ross Ference LLP announced today that it represented H.C. Wainwright & Co., LLC as exclusive placement agent in a $40.0 million public offering of the common stock of Pulmatrix, Inc. (NASDAQ: “PULM”), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and non-pulmonary disease using its patented iSPERSE™ technology. The registered direct offering with certain healthcare-focused institutional investors consisted of the sale 20,000,000 shares of common stock, for aggregate gross proceeds of approximately $40.0 million.

The shares of common stock were offered by Pulmatrix pursuant to a “shelf” registration statement on Form S-3 (File No. 333-230225) previously filed with the Securities and Exchange Commission (the “SEC”) on March 12, 2019 and declared effective by the SEC on March 15, 2019.

The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Arthur Marcus, Darrin M. Ocasio and law clerk Zachary Weiss.

Author
Recent Posts

Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry. In addition to handling routine to complex commercial matters, SRF’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations. The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation. Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies. The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA). These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct. Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records. The firm complements its core practice areas with an established commercial real estate and trusts and estates practice.

Visit SRF's LinkedIn page

Latest posts by Sichenzia Ross Ference LLP (see all)

Sichenzia Ross Ference LLP Announces Over 80 Capital Markets Transactions Valued Over $2 Billion at the Closing of 2021 - January 13, 2022
Sichenzia Ross Ference LLP Adds Two Key Additions to its Corporate and Securities Law Team - January 11, 2022
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $9.8 Million Underwritten Offering of BiondVax Pharmaceuticals Ltd. - December 30, 2021

Sichenzia Ross Ference LLP Represents H.C. Wainwright in $40.0 Million Registered Direct Offering of Pulmatrix, Inc.

Related Posts